Balyasny Asset Management’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,804
| Closed | -$59.6K | – | 2466 |
|
|
2025
Q1 | $59.6K | Buy |
+10,804
| New | +$59.6K | ﹤0.01% | 1931 |
|
|
2022
Q4 | – | Sell |
-286,532
| Closed | -$2.85M | – | 2745 |
|
|
2022
Q3 | $2.85M | Hold |
286,532
| – | – | 0.01% | 994 |
|
|
2022
Q2 | $2.82M | Hold |
286,532
| – | – | 0.01% | 986 |
|
|
2022
Q1 | $2.81M | Hold |
286,532
| – | – | 0.01% | 954 |
|
|
2021
Q4 | $2.83M | Hold |
286,532
| – | – | 0.01% | 908 |
|
|
2021
Q3 | $2.85M | Hold |
286,532
| – | – | 0.01% | 842 |
|
|
2021
Q2 | $2.8M | Hold |
286,532
| – | – | 0.01% | 807 |
|
|
2021
Q1 | $2.77M | Buy |
+286,532
| New | +$2.77M | 0.01% | 768 |
|